e-ISSN: Pending
Negative / Null Result ReportOpen accessTherapeutics. Pharmacology

Ineffective behavioral rescue despite partial brain Dp427 restoration by AAV9-U7-mediated exon 51 skipping in mdx52 mice

Ophélie Vacca; Amel Saoudi; Mathilde Doisy; Xaysongkhame Phongsavanh; Olivier Le Coz; Cathy Nagy; Julia Kuzniar; Cyrille Vaillend · 2025 · Molecular Therapy: Nucleic Acids

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

The mdx52 mouse model exhibits a common mutation profile associated with brain involvement in Duchenne muscular dystrophy (DMD), characterized by heightened anxiety, fearfulness, and impaired associative fear learning. Deletion of exon 52 disrupts the expression of two dystrophins found in the brain (Dp427 and Dp140) and is eligible for therapeutic exon-skipping strategies. We previously demonstrated that a single intracerebroventricular administration of an antisense oligonucleotide (ASO) targeting exon 51 of the Dmd gene could restore 5%–15% of Dp427 expression. This treatment reduced anxiet

Abstract by Ophélie Vacca; Amel Saoudi; Mathilde Doisy; Xaysongkhame Phongsavanh; Olivier Le Coz; Cathy Nagy; Julia Kuzniar; Cyrille Vaillend, Molecular Therapy: Nucleic Acids (2025) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: DOAJ · DOI 10.1016/j.omtn.2025.102779